The Institute participates in and leads numerous projects and studies aimed at improving patient care through new innovations and advancing knowledge. Find out about the latest fundamental and translational research projects and clinical studies.
Clinical studies :
Therapeutic areas: Gastroenterology, Endoscopy, Oncology, Hepatology, Chronic Inflammatory Bowel Disease (IBD), Digestive Surgery, Patient Cohorts, Biobanks, Health Data Collection, Endometriosis, etc.
Fondamental and Translational Research Projects :
Research areas: Gut-Brain Axis, Microbiota, Developmental Origin of Health and Diseases (DOHAD), First 1,000 Days, Nutrition, Chronic Inflammatory Bowel Diseases (IBD), Metabolism, Chronic Diseases, Neurodevelopment, Digestive Cancers, Spinal Cord Injury Pathologies, Infectious Diseases,
HEPATIMGO Network
The Western France Autoimmune Liver Disease Study and Research Network brings together all the hepatology and gastroenterology departments of university hospitals in western France to form a network for care, research, and teaching in the field of autoimmune liver diseases.
Study network led by Dr. Jérôme GOURNAY
> CHU de Nantes, Hépatites, GIRCI, prévention, biocollection
TOGAS – TOwards GAstric Cancer Screening Implementation in the European Union
There is no effective screening method in Europe for the prevention of gastric cancer. The overall objective of TOGAS is therefore to provide the missing evidence that can be used to design, plan, and implement appropriate gastric cancer prevention in the EU.
European project led at the IMAD Institute by Prof. Tamara MATYSIAK BUDNIK
> CHU de Nantes, gastric cancer, prevention
AIDA – an AI diagnostic assistant for detecting lesions before gastric cancer
The AIDA project aims to develop and validate a multidisciplinary AI-powered assistant that will help clinicians prevent gastric cancer by diagnosing precancerous gastric inflammation and suggesting personalized therapies and follow-up care.
European project led at IMAD by Prof. Tamara MATYSIAK BUDNIK
> CHU de Nantes, gastric cancer , prevention, IA,
ENDOMIC
ENDOMIC – Impact of gut microbiota on digestive disorders
in women with endometriosis
In the context of endometriosis, the project aims to better characterize the digestive disorders suffered by these patients, analyze the composition of their gut microbiota, and study its impact on digestive functions. The objective is to identify new treatments and/or improve current care.
+ Support from SanteDige
Translational research project led by Dr. Claire Cardaillac
> endometriosis, TENS Lab, Microbiota, CHU de Nantes
CELESTE – Nantes Cohort for Chronic Inflammatory Bowel Diseases
Cohort of IBD patients backed by a biobank (blood, microbiota, tissues) to enable better characterization, at the molecular and cellular level, of the heterogeneity of pathological immune mechanisms observed in different patients.
+ Support from SanteDige
Cohort and biobank project by Dr. Catherine LE BERRE
> Chronic Inflammatory Bowel Diseases, TENS and PhAN laboratories, Microbiota, Nantes University Hospital, Jules Verne Clinic (Nantes) and Confluent Clinic (Nantes), IBD-Next cluster, CIC-Imad
NEO-TOCC pilote
Pilot study of the value of personalized colonic tumoroids in predicting response to chemotherapy in patients with locally advanced non-metastatic colorectal cancer.
Led by Prof. Emilie Duchalais
+ Support from SanteDige
Translational research project led by Prof. Emilie DUCHALAIS
> Digestive cancers, TENS laboratory, Organoids, Nantes University Hospital, CIC-Imad
